Production (Stage)
Microbot Medical Inc.
MBOT
$2.62
-$0.02-0.76%
NASDAQ
| 03/31/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -49.89% | 151.37% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -11.92% | 3.94% | |||
| Operating Income | 11.92% | -3.94% | |||
| Income Before Tax | 23.32% | -5.51% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 23.32% | -5.51% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 23.32% | -5.51% | |||
| EBIT | 11.92% | -3.94% | |||
| EBITDA | 11.69% | -3.88% | |||
| EPS Basic | 57.58% | -1.08% | |||
| Normalized Basic EPS | 52.47% | -1.07% | |||
| EPS Diluted | 57.58% | -1.08% | |||
| Normalized Diluted EPS | 52.47% | -1.07% | |||
| Average Basic Shares Outstanding | 80.84% | 4.36% | |||
| Average Diluted Shares Outstanding | 80.84% | 4.36% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||